CORCEPT THERAPEUTICS INC — Director's Dealing 2021

Jan 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-01-19

Reporting Person: Swisher Daniel N JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-19	Common Stock	M	5000	$6.55	Acquired	5000	Direct
2021-01-19	Common Stock	S	5000	$28.7373	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-19	Stock Option (Right to Buy)	$6.55	M	5000	Disposed	2025-06-18	Common Stock (5000)	Direct

Footnotes

F1: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.

F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.56 to $29.05 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from Issuer upon request.

F3: Fully exercisable.